Company Details
dove-medical-press
131
3,485
511
dovepress.com
0
DOV_1583695
In-progress

Dove Medical Press Company CyberSecurity Posture
dovepress.comDove Medical Press Ltd is an online open access academic publisher specialising in science, technology and especially medicine. All 70 peer-reviewed journals are free to access online, allowing authors to disseminate their research to a global audience. Most of our journals are widely indexed in databases such as PubMed, Scopus and DOAJ, and an increasing number have Impact Factors. We are a member of OASPA, COPE and HINARI, and are committed to publishing good scientific research and giving authors around the world the opportunity to publish and share their research findings. We have an efficient and rigorous peer-review process. Due to this, many of our journals are able to provide authors with an initial editorial decision within four to five weeks. We aim to provide the highest possible standard of service to our authors. Recent feedback from an author survey demonstrated that: • 100% of authors surveyed found the online manuscript system easy to use • 100% of authors surveyed agreed that they received professional accurate service • 97% of authors surveyed would submit a manuscript with us again • 96% of authors surveyed received prompt communication throughout the publishing process • 86% of authors surveyed rated their level of satisfaction as Excellent (the other 14% rated us as good) To view testimonials from more of our authors please visit: https://www.dovepress.com/testimonials.php We have offices in the United Kingdom, USA and New Zealand. Dove Medical Press is part of Taylor & Francis Group, the Academic Publishing Division of Informa PLC.
Company Details
dove-medical-press
131
3,485
511
dovepress.com
0
DOV_1583695
In-progress
Between 750 and 799

DMP Global Score (TPRM)XXXX



No incidents recorded for Dove Medical Press in 2025.
No incidents recorded for Dove Medical Press in 2025.
No incidents recorded for Dove Medical Press in 2025.
DMP cyber incidents detection timeline including parent company and subsidiaries

Dove Medical Press Ltd is an online open access academic publisher specialising in science, technology and especially medicine. All 70 peer-reviewed journals are free to access online, allowing authors to disseminate their research to a global audience. Most of our journals are widely indexed in databases such as PubMed, Scopus and DOAJ, and an increasing number have Impact Factors. We are a member of OASPA, COPE and HINARI, and are committed to publishing good scientific research and giving authors around the world the opportunity to publish and share their research findings. We have an efficient and rigorous peer-review process. Due to this, many of our journals are able to provide authors with an initial editorial decision within four to five weeks. We aim to provide the highest possible standard of service to our authors. Recent feedback from an author survey demonstrated that: • 100% of authors surveyed found the online manuscript system easy to use • 100% of authors surveyed agreed that they received professional accurate service • 97% of authors surveyed would submit a manuscript with us again • 96% of authors surveyed received prompt communication throughout the publishing process • 86% of authors surveyed rated their level of satisfaction as Excellent (the other 14% rated us as good) To view testimonials from more of our authors please visit: https://www.dovepress.com/testimonials.php We have offices in the United Kingdom, USA and New Zealand. Dove Medical Press is part of Taylor & Francis Group, the Academic Publishing Division of Informa PLC.

.png)
Breach reporting data from the HHS' Office for Civil Rights (OCR) is starting to show a reduction in healthcare data breaches.
The federal privacy watchdog has launched an investigation into a cybersecurity breach at a company that stores the personal information of K-12 students...
Our HIPAA breach news section covers HIPAA breaches such as unauthorized disclosures of protected health information (PHI), improper disposal of PHI.

Explore insights on cybersecurity incidents, risk posture, and Rankiteo's assessments.
The official website of Dove Medical Press is http://www.dovepress.com.
According to Rankiteo, Dove Medical Press’s AI-generated cybersecurity score is 752, reflecting their Fair security posture.
According to Rankiteo, Dove Medical Press currently holds 0 security badges, indicating that no recognized compliance certifications are currently verified for the organization.
According to Rankiteo, Dove Medical Press is not certified under SOC 2 Type 1.
According to Rankiteo, Dove Medical Press does not hold a SOC 2 Type 2 certification.
According to Rankiteo, Dove Medical Press is not listed as GDPR compliant.
According to Rankiteo, Dove Medical Press does not currently maintain PCI DSS compliance.
According to Rankiteo, Dove Medical Press is not compliant with HIPAA regulations.
According to Rankiteo,Dove Medical Press is not certified under ISO 27001, indicating the absence of a formally recognized information security management framework.
Dove Medical Press operates primarily in the Book and Periodical Publishing industry.
Dove Medical Press employs approximately 131 people worldwide.
Dove Medical Press presently has no subsidiaries across any sectors.
Dove Medical Press’s official LinkedIn profile has approximately 3,485 followers.
Dove Medical Press is classified under the NAICS code 511, which corresponds to Publishing Industries (except Internet).
No, Dove Medical Press does not have a profile on Crunchbase.
Yes, Dove Medical Press maintains an official LinkedIn profile, which is actively utilized for branding and talent engagement, which can be accessed here: https://www.linkedin.com/company/dove-medical-press.
As of November 28, 2025, Rankiteo reports that Dove Medical Press has not experienced any cybersecurity incidents.
Dove Medical Press has an estimated 4,881 peer or competitor companies worldwide.
Total Incidents: According to Rankiteo, Dove Medical Press has faced 0 incidents in the past.
Incident Types: The types of cybersecurity incidents that have occurred include .
.png)
ThingsBoard in versions prior to v4.2.1 allows an authenticated user to upload malicious SVG images via the "Image Gallery", leading to a Stored Cross-Site Scripting (XSS) vulnerability. The exploit can be triggered when any user accesses the public API endpoint of the malicious SVG images, or if the malicious images are embedded in an `iframe` element, during a widget creation, deployed to any page of the platform (e.g., dashboards), and accessed during normal operations. The vulnerability resides in the `ImageController`, which fails to restrict the execution of JavaScript code when an image is loaded by the user's browser. This vulnerability can lead to the execution of malicious code in the context of other users' sessions, potentially compromising their accounts and allowing unauthorized actions.
Mattermost versions 11.0.x <= 11.0.2, 10.12.x <= 10.12.1, 10.11.x <= 10.11.4, 10.5.x <= 10.5.12 fail to to verify that the token used during the code exchange originates from the same authentication flow, which allows an authenticated user to perform account takeover via a specially crafted email address used when switching authentication methods and sending a request to the /users/login/sso/code-exchange endpoint. The vulnerability requires ExperimentalEnableAuthenticationTransfer to be enabled (default: enabled) and RequireEmailVerification to be disabled (default: disabled).
Mattermost versions 11.0.x <= 11.0.2, 10.12.x <= 10.12.1, 10.11.x <= 10.11.4, 10.5.x <= 10.5.12 fail to sanitize team email addresses to be visible only to Team Admins, which allows any authenticated user to view team email addresses via the GET /api/v4/channels/{channel_id}/common_teams endpoint
Exposure of email service credentials to users without administrative rights in Devolutions Server.This issue affects Devolutions Server: before 2025.2.21, before 2025.3.9.
Exposure of credentials in unintended requests in Devolutions Server.This issue affects Server: through 2025.2.20, through 2025.3.8.

Get company history
Every week, Rankiteo analyzes billions of signals to give organizations a sharper, faster view of emerging risks. With deeper, more actionable intelligence at their fingertips, security teams can outpace threat actors, respond instantly to Zero-Day attacks, and dramatically shrink their risk exposure window.
Identify exposed access points, detect misconfigured SSL certificates, and uncover vulnerabilities across the network infrastructure.
Gain visibility into the software components used within an organization to detect vulnerabilities, manage risk, and ensure supply chain security.
Monitor and manage all IT assets and their configurations to ensure accurate, real-time visibility across the company's technology environment.
Leverage real-time insights on active threats, malware campaigns, and emerging vulnerabilities to proactively defend against evolving cyberattacks.